Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.

Key Points

• This report highlights crucial gaps in the clinical translation of precision medicine for diabetes, indicating areas needing improvement.
• It identifies a need for integrating genomics and biomarkers to enhance diabetes treatment tailored to individual patients.
• Consensus was reached across international experts employing systematic review of current practices and guidelines in diabetes care.
• Findings suggest focusing on collaboration among researchers, healthcare providers, and policymakers might improve precision medicine approaches.